Speciality
Spotlight

 




           

Clinical Pharmacology

       

     





Heart
Failure

   

  • Iain
    B Squire & David B. Barnett (Department of
    Medicine and Therapeutics, University of Leicester,
    UK)

    The
    rational use of
    b-adrenoceptor
    blockers in the treatment of heart failure. 
    The changing face of an old therapy.

    Br.J.Clin
    Pharmacol, 49, 1-9.

     

    Summary
    : The concept of using beta-blockers in the
    treatment of heart failure was introduced in the
    1970s. There
    is a common belief that beta-blockade is
    contraindicated in treatment of patients with stable
    chronic heart failure.

     

    The
    case for a beneficial effect of beta-blockade in
    patients with stable, chronic heart failure is
    established. Available
    data pertains to mild to moderate heart failure. Studies have shown benefit in terms of morbidity and mortality.

       



  
 



 

     

Speciality Spotlight

 

           
Clinical Pharmacology
       

     

Heart Failure
   

  • Iain B Squire & David B. Barnett (Department of Medicine and Therapeutics, University of Leicester, UK)
    The rational use of b-adrenoceptor blockers in the treatment of heart failure.  The changing face of an old therapy.
    Br.J.Clin Pharmacol, 49, 1-9.
     
    Summary : The concept of using beta-blockers in the treatment of heart failure was introduced in the 1970s. There is a common belief that beta-blockade is contraindicated in treatment of patients with stable chronic heart failure.
     
    The case for a beneficial effect of beta-blockade in patients with stable, chronic heart failure is established. Available data pertains to mild to moderate heart failure. Studies have shown benefit in terms of morbidity and mortality.
       

    

 

By |2022-07-20T16:42:12+00:00July 20, 2022|Uncategorized|Comments Off on Heart Failure

About the Author: